BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33762363)

  • 1. Comparative Performance of Latest-Generation and FDA-Cleared Serology Tests for the Diagnosis of Chagas Disease.
    Kelly EA; Bulman CA; Gunderson EL; Irish AM; Townsend RL; Sakanari JA; Stramer SL; Bern C; Whitman JD
    J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33762363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chagas Disease Serological Test Performance in U.S. Blood Donor Specimens.
    Whitman JD; Bulman CA; Gunderson EL; Irish AM; Townsend RL; Stramer SL; Sakanari JA; Bern C
    J Clin Microbiol; 2019 Dec; 57(12):. PubMed ID: 31511333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Elecsys Chagas Assay for Detection of Trypanosoma cruzi-Specific Antibodies in a Multicenter Study in Europe and Latin America.
    Flores-Chavez MD; Sambri V; Schottstedt V; Higuera-Escalante FA; Roessler D; Chaves M; Laengin T; Martinez A; Fleischer B
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29444836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic Variations in Test Reactivity for the Serological Diagnosis of Trypanosoma cruzi Infection.
    Truyens C; Dumonteil E; Alger J; Cafferata ML; Ciganda A; Gibbons L; Herrera C; Sosa-Estani S; Buekens P
    J Clin Microbiol; 2021 Nov; 59(12):e0106221. PubMed ID: 34469183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi.
    Brashear RJ; Winkler MA; Schur JD; Lee H; Burczak JD; Hall HJ; Pan AA
    Transfusion; 1995 Mar; 35(3):213-8. PubMed ID: 7878713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a Latent Class Analysis in the Diagnosis of Chronic Chagas Disease in the Washington Metropolitan Area.
    Castro-Sesquen YE; Saldaña A; Patino Nava D; Bayangos T; Paulette Evans D; DeToy K; Trevino A; Marcus R; Bern C; Gilman RH; Talaat KR;
    Clin Infect Dis; 2021 May; 72(9):e303-e310. PubMed ID: 32766826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.
    Gupta S; Wan X; Zago MP; Sellers VC; Silva TS; Assiah D; Dhiman M; Nuñez S; Petersen JR; Vázquez-Chagoyán JC; Estrada-Franco JG; Garg NJ
    PLoS Negl Trop Dis; 2013; 7(1):e2018. PubMed ID: 23350012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic.
    Guzmán-Gómez D; López-Monteon A; de la Soledad Lagunes-Castro M; Álvarez-Martínez C; Hernández-Lutzon MJ; Dumonteil E; Ramos-Ligonio A
    Parasit Vectors; 2015 Sep; 8():466. PubMed ID: 26384317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Abbott ARCHITECT Chagas prototype assay.
    Praast G; Herzogenrath J; Bernhardt S; Christ H; Sickinger E
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):74-81. PubMed ID: 21146717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a prototype Trypanosoma cruzi antibody assay with recombinant antigens on a fully automated chemiluminescence analyzer for blood donor screening.
    Chang CD; Cheng KY; Jiang LX; Salbilla VA; Haller AS; Yem AW; Bryant JD; Kirchhoff LV; Leiby DA; Schochetman G; Shah DO
    Transfusion; 2006 Oct; 46(10):1737-44. PubMed ID: 17002630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lineage-specific rapid diagnostic tests can resolve Trypanosoma cruzi TcII/V/VI ecological and epidemiological associations in the Argentine Chaco.
    Murphy N; Macchiaverna NP; Victoria Cardinal M; Bhattacharyya T; Mertens P; Zeippen N; Gustin Y; Gilleman Q; Gürtler RE; Miles MA
    Parasit Vectors; 2019 Sep; 12(1):424. PubMed ID: 31522683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay.
    Malan AK; Avelar E; Litwin SE; Hill HR; Litwin CM
    J Med Microbiol; 2006 Feb; 55(Pt 2):171-178. PubMed ID: 16434709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of matrix effects and prolonged storage on Trypanosoma cruzi serology in blood donor specimens.
    Whitman JD; Townsend RL; Bern C; Stramer SL
    Transfusion; 2020 Jun; 60(6):1149-1153. PubMed ID: 32163175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples.
    Luquetti AO; Espinoza B; Martínez I; Hernández-Becerril N; Ponce C; Ponce E; Reyes PA; Hernández O; López R; Monteón V
    Mem Inst Oswaldo Cruz; 2009 Aug; 104(5):797-800. PubMed ID: 19820845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors.
    Tobler LH; Contestable P; Pitina L; Groth H; Shaffer S; Blackburn GR; Warren H; Lee SR; Busch MP
    Transfusion; 2007 Jan; 47(1):90-6. PubMed ID: 17207235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of seven diagnostic tests to detect Trypanosoma cruzi infection in patients in chronic phase of Chagas disease.
    Duarte LF; Flórez O; Rincón G; González CI
    Colomb Med (Cali); 2014; 45(2):61-6. PubMed ID: 25100890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic.
    Daltro RT; Leony LM; Freitas NEM; Silva ÂAO; Santos EF; Del-Rei RP; Brito MEF; Brandão-Filho SP; Gomes YM; Silva MS; Donato ST; Jeronimo SMB; Monteiro GRG; Carvalho LP; Magalhães AS; Zanchin NIT; Celedon PAF; Santos FLN
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease - a Phase II study.
    Santos FL; Celedon PA; Zanchin NI; de Souza WV; da Silva ED; Foti L; Krieger MA; Gomes YM
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005433. PubMed ID: 28273127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a rapid and reliable test for diagnosis of chagas' disease by detection of Trypanosoma cruzi-specific antibodies in blood of donors and patients in Central America.
    Ponce C; Ponce E; Vinelli E; Montoya A; de Aguilar V; Gonzalez A; Zingales B; Rangel-Aldao R; Levin MJ; Esfandiari J; Umezawa ES; Luquetti AO; da Silveira JF
    J Clin Microbiol; 2005 Oct; 43(10):5065-8. PubMed ID: 16207963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Performance of Ortho T. cruzi ELISA Test System for the Detection of Antibodies to Trypanosoma cruzi.
    Rivera HN; McAuliffe I; Aderohunmu T; Wiegand RE; Montgomery SP; Bradbury RS; Handali S
    J Clin Microbiol; 2022 Aug; 60(8):e0013422. PubMed ID: 35862752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.